IFPMA News
Most Popular IFPMA Story
Novartis, trade group at odds on Sandoz
Amazing what's going on behind closed doors at the International Federation of Pharmaceutical Manufacturers and Associations. As IFPMA is concluding a probe of Sandoz, the generics arm of Novartis, Read more...
Latest Headlines
- February 17, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
